175 related articles for article (PubMed ID: 33186495)
1. Advances in the Treatment of Chronic Pain by Targeting GPCRs.
Che T
Biochemistry; 2021 May; 60(18):1401-1412. PubMed ID: 33186495
[TBL] [Abstract][Full Text] [Related]
2. Targeting G protein-coupled receptors for the treatment of chronic pain in the digestive system.
Gottesman-Katz L; Latorre R; Vanner S; Schmidt BL; Bunnett NW
Gut; 2021 May; 70(5):970-981. PubMed ID: 33272979
[TBL] [Abstract][Full Text] [Related]
3. Targeting G protein coupled receptors for alleviating neuropathic pain.
Kumari P; Yadav A; Patel M; Yadav PN
Prog Mol Biol Transl Sci; 2022; 193(1):99-117. PubMed ID: 36357081
[TBL] [Abstract][Full Text] [Related]
4. Modulation of pain transmission by G-protein-coupled receptors.
Pan HL; Wu ZZ; Zhou HY; Chen SR; Zhang HM; Li DP
Pharmacol Ther; 2008 Jan; 117(1):141-61. PubMed ID: 17959251
[TBL] [Abstract][Full Text] [Related]
5. G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides.
Daniel JT; Clark RJ
Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29144441
[TBL] [Abstract][Full Text] [Related]
6. Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neurons.
Sadeghi M; McArthur JR; Finol-Urdaneta RK; Adams DJ
Neuropharmacology; 2017 Dec; 127():116-123. PubMed ID: 28533165
[TBL] [Abstract][Full Text] [Related]
7. Novel G protein-coupled receptors as pain targets.
Ahmad S; Dray A
Curr Opin Investig Drugs; 2004 Jan; 5(1):67-70. PubMed ID: 14983976
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
9. [Pathophysiology of low back pain and the transition to the chronic state - experimental data and new concepts].
Mense S
Schmerz; 2001 Dec; 15(6):413-7. PubMed ID: 11793144
[TBL] [Abstract][Full Text] [Related]
10. Targeting cell surface trafficking of pain-facilitating receptors to treat chronic pain conditions.
Ma W; Quirion R
Expert Opin Ther Targets; 2014 Apr; 18(4):459-72. PubMed ID: 24512266
[TBL] [Abstract][Full Text] [Related]
11. Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.
Moutal A; Li W; Wang Y; Ju W; Luo S; Cai S; François-Moutal L; Perez-Miller S; Hu J; Dustrude ET; Vanderah TW; Gokhale V; Khanna M; Khanna R
Br J Pharmacol; 2018 Jun; 175(12):2244-2260. PubMed ID: 28161890
[TBL] [Abstract][Full Text] [Related]
12. Kainate receptor signaling in pain pathways.
Bhangoo SK; Swanson GT
Mol Pharmacol; 2013 Feb; 83(2):307-15. PubMed ID: 23095167
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive effect of selective G protein-gated inwardly rectifying K+ channel agonist ML297 in the rat spinal cord.
Kimura M; Shiokawa H; Karashima Y; Sumie M; Hoka S; Yamaura K
PLoS One; 2020; 15(9):e0239094. PubMed ID: 32915912
[TBL] [Abstract][Full Text] [Related]
14. Human sensory neuron-specific Mas-related G protein-coupled receptors-X1 sensitize and directly activate transient receptor potential cation channel V1 via distinct signaling pathways.
Solinski HJ; Zierler S; Gudermann T; Breit A
J Biol Chem; 2012 Nov; 287(49):40956-71. PubMed ID: 23074220
[TBL] [Abstract][Full Text] [Related]
15. The Role of Voltage-Gated Sodium Channels in Pain Signaling.
Bennett DL; Clark AJ; Huang J; Waxman SG; Dib-Hajj SD
Physiol Rev; 2019 Apr; 99(2):1079-1151. PubMed ID: 30672368
[TBL] [Abstract][Full Text] [Related]
16. The G protein-coupled receptor-transient receptor potential channel axis: molecular insights for targeting disorders of sensation and inflammation.
Veldhuis NA; Poole DP; Grace M; McIntyre P; Bunnett NW
Pharmacol Rev; 2015; 67(1):36-73. PubMed ID: 25361914
[TBL] [Abstract][Full Text] [Related]
17. Orexins/hypocretins: pain regulation and cellular actions.
Chiou LC; Lee HJ; Ho YC; Chen SP; Liao YY; Ma CH; Fan PC; Fuh JL; Wang SJ
Curr Pharm Des; 2010; 16(28):3089-100. PubMed ID: 20687883
[TBL] [Abstract][Full Text] [Related]
18. Regulators of G protein signalling as pharmacological targets for the treatment of neuropathic pain.
Doyen PJ; Beckers P; Brook GA; Hermans E
Pharmacol Res; 2020 Oct; 160():105148. PubMed ID: 32858121
[TBL] [Abstract][Full Text] [Related]
19. Na
McKerrall SJ; Sutherlin DP
Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
[TBL] [Abstract][Full Text] [Related]
20. T-type calcium channels in chronic pain: mouse models and specific blockers.
François A; Laffray S; Pizzoccaro A; Eschalier A; Bourinet E
Pflugers Arch; 2014 Apr; 466(4):707-17. PubMed ID: 24590509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
